1. Home
  2. SPRC vs POAI Comparison

SPRC vs POAI Comparison

Compare SPRC & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • POAI
  • Stock Information
  • Founded
  • SPRC 2004
  • POAI 2002
  • Country
  • SPRC Israel
  • POAI United States
  • Employees
  • SPRC N/A
  • POAI N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • POAI Industrial Specialties
  • Sector
  • SPRC Health Care
  • POAI Health Care
  • Exchange
  • SPRC Nasdaq
  • POAI Nasdaq
  • Market Cap
  • SPRC 7.3M
  • POAI 7.8M
  • IPO Year
  • SPRC N/A
  • POAI N/A
  • Fundamental
  • Price
  • SPRC $4.27
  • POAI $9.39
  • Analyst Decision
  • SPRC
  • POAI Hold
  • Analyst Count
  • SPRC 0
  • POAI 1
  • Target Price
  • SPRC N/A
  • POAI N/A
  • AVG Volume (30 Days)
  • SPRC 7.0M
  • POAI 252.1K
  • Earning Date
  • SPRC 01-01-0001
  • POAI 11-11-2025
  • Dividend Yield
  • SPRC N/A
  • POAI N/A
  • EPS Growth
  • SPRC N/A
  • POAI N/A
  • EPS
  • SPRC N/A
  • POAI N/A
  • Revenue
  • SPRC $1,306,000.00
  • POAI $1,664,696.00
  • Revenue This Year
  • SPRC N/A
  • POAI $486.27
  • Revenue Next Year
  • SPRC N/A
  • POAI $65.50
  • P/E Ratio
  • SPRC N/A
  • POAI N/A
  • Revenue Growth
  • SPRC N/A
  • POAI 71.65
  • 52 Week Low
  • SPRC $1.75
  • POAI $9.14
  • 52 Week High
  • SPRC $37.59
  • POAI $45.90
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 50.89
  • POAI 50.16
  • Support Level
  • SPRC $3.75
  • POAI $9.14
  • Resistance Level
  • SPRC $4.48
  • POAI $14.65
  • Average True Range (ATR)
  • SPRC 0.50
  • POAI 1.20
  • MACD
  • SPRC -0.06
  • POAI -0.87
  • Stochastic Oscillator
  • SPRC 38.85
  • POAI 2.99

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: